» Articles » PMID: 32290206

The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of

Overview
Journal J Fungi (Basel)
Date 2020 Apr 16
PMID 32290206
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The first characterized antifungal in the orotomide class is olorofim. It targets the de novo pyrimidine biosynthesis pathway by inhibiting dihydroorotate dehydrogenase (DHODH). The pyrimidines uracil, thymine and cytosine are the building blocks of DNA and RNA; thus, inhibition of their synthesis is likely to have multiple effects, including affecting cell cycle regulation and protein synthesis. Additionally, uridine-5'-triphosphate (UTP) is required for the formation of uridine-diphosphate glucose (UDP-glucose), which is an important precursor for several cell wall components. In this study, the dynamic effects of olorofim treatment on the morphology and organization of hyphae were analyzed microscopically using confocal live-cell imaging. Treatment with olorofim led to increased chitin content in the cell wall, increased septation, enlargement of vacuoles and inhibition of mitosis. Furthermore, vesicle-like structures, which could not be stained or visualized with a range of membrane- or vacuole-selective dyes, were found in treated hyphae. A colocalization study of DHODH and MitoTracker Red FM confirmed for the first time that DHODH is localized in the mitochondria. Overall, olorofim treatment was found to significantly influence the dynamic structure and organization of hyphae.

Citing Articles

FpnA, the Aspergillus fumigatus homolog of human ferroportin, mediates resistance to nickel, cobalt and gallium but does not function in iron homeostasis.

Happacher I, Oberegger S, Abt B, Yap A, Caballero P, Aguiar M Commun Biol. 2025; 8(1):399.

PMID: 40057608 PMC: 11890741. DOI: 10.1038/s42003-025-07799-1.


The proteomic response of to amphotericin B (AmB) reveals the involvement of the RTA-like protein RtaA in AmB resistance.

Abou-Kandil A, Troger-Gorler S, Pschibul A, Kruger T, Rosin M, Schmidt F Microlife. 2025; 6:uqae024.

PMID: 39790482 PMC: 11707875. DOI: 10.1093/femsml/uqae024.


New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.

Nino-Vega G, Padro-Villegas L, Lopez-Romero E J Fungi (Basel). 2024; 10(12).

PMID: 39728367 PMC: 11678429. DOI: 10.3390/jof10120871.


Shining a light on the impact of antifungals on subcellular dynamics through fluorescence imaging.

Storer I, Sastre-Velasquez L, Easter T, Mertens B, Dallemulle A, Bottery M Antimicrob Agents Chemother. 2024; 68(11):e0080324.

PMID: 39404344 PMC: 11539212. DOI: 10.1128/aac.00803-24.


The Role of Olorofim in the Treatment of Filamentous Fungal Infections: A Review of In Vitro and In Vivo Studies.

Feuss A, Bougnoux M, Dannaoui E J Fungi (Basel). 2024; 10(5).

PMID: 38786700 PMC: 11121921. DOI: 10.3390/jof10050345.


References
1.
Punt P, Oliver R, Dingemanse M, Pouwels P, van den Hondel C . Transformation of Aspergillus based on the hygromycin B resistance marker from Escherichia coli. Gene. 1987; 56(1):117-24. DOI: 10.1016/0378-1119(87)90164-8. View

2.
Gow N, Latge J, Munro C . The Fungal Cell Wall: Structure, Biosynthesis, and Function. Microbiol Spectr. 2017; 5(3). PMC: 11687499. DOI: 10.1128/microbiolspec.FUNK-0035-2016. View

3.
Liu S, Neidhardt E, Grossman T, Ocain T, Clardy J . Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure. 2000; 8(1):25-33. DOI: 10.1016/s0969-2126(00)00077-0. View

4.
Brown G, Denning D, Gow N, Levitz S, Netea M, White T . Hidden killers: human fungal infections. Sci Transl Med. 2012; 4(165):165rv13. DOI: 10.1126/scitranslmed.3004404. View

5.
Small I, Peeters N, Legeai F, Lurin C . Predotar: A tool for rapidly screening proteomes for N-terminal targeting sequences. Proteomics. 2004; 4(6):1581-90. DOI: 10.1002/pmic.200300776. View